TrialInternational journal of clinical pharmacology and therapeutics2015

Characterization of the relationship between dose and blood eosinophil response following subcutaneous administration of mepolizumab.

Isabelle J Pouliquen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.